Skip to main content

Ethics Law and Governance of Biobanking: A Very Complex Normative Puzzle

  • Chapter
  • First Online:
Ethics, Law and Governance of Biobanking

Part of the book series: The International Library of Ethics, Law and Technology ((ELTE,volume 14))

Abstract

The Food and Drug Administration in the US recently granted premarket clearance for a DNA sequencing platform with increased diagnostic power. Collins et al. stated in an editorial in the New England Journal of Medicine that this approval may open the door “for the development and use of innumerable new genome-based tests” (Collins et al., NEJM 369:2369–2371, 2013). Collins et al. called the approval “a landmark move that will finally open the way to realize the promise of personalized medicine” (Collins et al., NEJM 369:2369–2371, 2013).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Collins F.S, et al. 2013. First FDA Authorization for next-generation sequencer. NEJM 369(25): 2369–2371. doi:10.1056/NEJM.

  • Mascalzoni D., et al. 2013. Rare diseases and now rare data. Nature Reviews Genetics 14: 372. doi:10.1038/nrg3494.

  • Mascalzoni D., et al. 2014. Rare diseases research; breaking the privacy barriers. Applied and Translational Genomics 3(2): 23–29.

    Google Scholar 

  • McNally, E., et al. 2004. Ethical, legal and social aspects of genetic testing: research, development and clinical applications. Brussels: Research Directorate General of the European Commission.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deborah Mascalzoni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Mascalzoni, D. (2015). Ethics Law and Governance of Biobanking: A Very Complex Normative Puzzle. In: Mascalzoni, D. (eds) Ethics, Law and Governance of Biobanking. The International Library of Ethics, Law and Technology, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9573-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-9573-9_1

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-9572-2

  • Online ISBN: 978-94-017-9573-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics